clear all
Auto Physical Damage Article

Plugged-In: EV Collision Insights 2023 Year in Review

March 7, 2024

2023 ended with electric vehicle (EV) repairable claims frequency at 1.97% in the United States and 2.86% in Canada. That represents an increase of more than 40% in both regions over the previous year. When compared to 2020, the frequency of claims for repairable EVs has more than tripled.

Enlyte Article

Enhancing Provider Networks: Coventry's Quality Improvement Program

March 5, 2024

Optimize Your Provider Network Quality with Coventry's Improvement Program Today!

Enlyte Article

Ask The Pharmacist: The Role of a Pharmacy and Therapeutics (P&T) Committee

March 1, 2024

A Pharmacy and Therapeutics (P&T) committee plays a crucial role in the realm of health care, particularly in the context of a workers’ compensation pharmacy benefit manager (PBM). This committee is comprised of health care professionals, such as physicians and pharmacists, who are responsible for evaluating and making decisions about the formulary—a continually updated list of medications covered by a prescription drug plan.

Enlyte Podcast

Closing Loopholes: Tackling Drug Price Inflation in Work Comp

February 22, 2024

Auto Physical Damage Article

ADAS Calibration: The New Profit Center

February 12, 2024

While the U.S. has made significant progress in improving motor vehicle safety since the fatality rate hit its peak nearly a hundred years ago, there’s still work to do. Excessive speed continues to be a significant contributing factor in traffic deaths and injuries, along with the rise in distracted driving.

Auto Physical Damage Conference


The highly anticipated NORTHEAST automotive repair event is tailored to meet the diverse needs of professionals across the industry. The conference offers a mix of seminars, presentations, product demos and activities with opportunities for networking and learning. Discover the latest industry insights, procedures and cutting-edge products, all in one setting.

Enlyte Article

Ask The Pharmacist: Risk Assessment for Opioid Use Disorder (OUD)

February 6, 2024

On December 19, 2023, the U.S. Food and Drug Administration (FDA) approved the first test (AvertD) that uses DNA in assessing whether certain individuals may have an elevated risk of developing opioid use disorder (OUD).


Technology and Expertise Driving Better Claims Outcomes

Mitchell simplifies and accelerates claims management and collision repair processes through the broadest range of technology solutions, networks, and partners in the P&C industry.

Learn More

Helping Injured Workers Get Better, Faster.

Genex helps injured employees return to their jobs in a safe and efficient manner through compassionate case management while reducing total claim cost.

Learn More

Sign up to Learn More